193 related articles for article (PubMed ID: 8280289)
21. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
22. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
23. Structural investigations of acridine derivatives by CoMFA and CoMSIA reveal novel insight into their structures toward DNA G-quadruplex mediated telomerase inhibition and offer a highly predictive 3D-model for substituted acridines.
Zambre VP; Murumkar PR; Giridhar R; Yadav MR
J Chem Inf Model; 2009 May; 49(5):1298-311. PubMed ID: 19413274
[TBL] [Abstract][Full Text] [Related]
24. CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.
Datar P; Desai P; Coutinho E; Iyer K
J Mol Model; 2002 Oct; 8(10):290-301. PubMed ID: 12483229
[TBL] [Abstract][Full Text] [Related]
25. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
[TBL] [Abstract][Full Text] [Related]
27. Comparative molecular field analysis of a series of paclitaxel analogues.
Zhu Q; Guo Z; Huang N; Wang M; Chu F
J Med Chem; 1997 Dec; 40(26):4319-28. PubMed ID: 9435901
[TBL] [Abstract][Full Text] [Related]
28. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
[TBL] [Abstract][Full Text] [Related]
29. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes.
Tong W; Perkins R; Xing L; Welsh WJ; Sheehan DM
Endocrinology; 1997 Sep; 138(9):4022-5. PubMed ID: 9275094
[TBL] [Abstract][Full Text] [Related]
30. Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents.
Carrigan SW; Fox PC; Wall ME; Wani MC; Bowen JP
J Comput Aided Mol Des; 1997 Jan; 11(1):71-8. PubMed ID: 9139114
[TBL] [Abstract][Full Text] [Related]
31. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
Yuan H; Kozikowski AP; Petukhov PA
J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity and mode of action of substituted indan-1, 3-diones in murine and human tissue cultured cells.
Hall IH; Wong OT; Chi LK; Chen SY
Anticancer Res; 1994; 14(5A):2053-8. PubMed ID: 7847849
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.
Oprea TI; García AE
J Comput Aided Mol Des; 1996 Jun; 10(3):186-200. PubMed ID: 8808736
[TBL] [Abstract][Full Text] [Related]
34. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Holder S; Lilly M; Brown ML
Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
[TBL] [Abstract][Full Text] [Related]
35. 3D-QSAR studies on caspase-mediated apoptosis activity of phenolic analogues.
Wang Y; Zhang H; Lin Y; Zhao Q; Liu H; Zhang Z; Xia Q; Zhu B; Lin Z
J Mol Model; 2011 Jan; 17(1):1-8. PubMed ID: 20306277
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of some new pyranoxanthenone aminoderivatives with cytotoxic activity.
Kolokythas G; Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H
Bioorg Med Chem Lett; 2002 Jun; 12(11):1443-6. PubMed ID: 12031316
[TBL] [Abstract][Full Text] [Related]
37. 3D-QSAR CoMFA study of some Heteroarylpyrroles as Possible Anticandida Agents.
Sharma PC; Sharma SV; Sharma A; Suresh B
Indian J Pharm Sci; 2008; 70(2):154-8. PubMed ID: 20046704
[TBL] [Abstract][Full Text] [Related]
38. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazones.
Dimmock JR; Advikolanu KM; Scott HE; Duffy MJ; Reid RS; Quail JW; Jia Z; Hickie RA; Allen TM; Rutledge JM
J Pharm Sci; 1992 Dec; 81(12):1147-52. PubMed ID: 1491328
[TBL] [Abstract][Full Text] [Related]
40. CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds.
Patel MR; Dimmock JR; Talele TT
J Chem Inf Model; 2007; 47(6):2110-23. PubMed ID: 17944456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
